Cat.#: ACPP-1357
| Despition | P2Y12 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1542 | Human GSK3B Protein , sf9 (AC1542) | 2 µg | inquiry |
| ACPP-1596 | Human SPG21 Protein (AC1596) | 5 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1474 | Human RGS21 Protein (AC1474) | 5 µg | inquiry |
| ACPP-1074 | Myocilin Blocking Peptide (AC1074) | 250 µg | inquiry |
| ACPP-1728 | Human Human C Peptide (Active) Protein (AC1728) | 100 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1113 | Native Porcine GFAP Protein (AC1113) | 25 µl | inquiry |
| ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg | inquiry |
| ACPP-1411 | Human NDEL1 Protein (AC1411) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.